data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+Español
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+Italiano
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+Français
QQQ
––%
DIA
––%
SPY
––%
TLT
––%
GLD
––%
BTC/USD
––%
Contribute
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+Español
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+Italiano
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+Français
Personal Finance
Alts
Best Real Estate Crowdfunding Platforms
REITs Versus Crowdfunding
How to Invest in Artwork
Best Alternative Investments
Best Alternative Investment Platforms
Crypto
Cannabis
News
Earnings
Interviews
Deals
Regulations
Psychedelics
TV
YouTube
Video
Podcasts
Trading School
My Stocks
Tools
Premium
QQQ
––%
DIA
––%
SPY
––%
TLT
––%
GLD
––%
BTC/USD
––%
Athersys
(NASDAQ:ATHX)
$0.2477
At close: Jul 6
$0.2479
0.0002[0.08%]
PreMarket: 4:38AM EDT
Day High/Low- - -
52 Week High/Low0.18 - 1.81
Open / Close- / -
Float / Outstanding246.9M / 263.9M
Vol / Avg.34.7K / 7.3M
Mkt Cap65.4M
P/E-
50d Avg. Price0.39
Div / Yield-
Payout Ratio-
EPS-0.09
Total Float246.9M

Athersys (NASDAQ:ATHX), Quotes and News Summary

Athersys (NASDAQ: ATHX)

Day High/Low- - -
52 Week High/Low0.18 - 1.81
Open / Close- / -
Float / Outstanding246.9M / 263.9M
Vol / Avg.34.7K / 7.3M
Mkt Cap65.4M
P/E-
50d Avg. Price0.39
Div / Yield-
Payout Ratio-
EPS-0.09
Total Float246.9M
Benzinga - Sponsored
Benzinga - 6 days ago
Benzinga - May 23, 2022, 6:04AM
Benzinga - May 20, 2022, 10:21AM
Benzinga - May 20, 2022, 9:28AM
Benzinga - May 12, 2022, 5:34PM
Benzinga - May 6, 2022, 8:11AM
Benzinga - May 5, 2022, 5:29PM
Benzinga - Apr 12, 2022, 2:09PM
Sector: Health Care.Industry: Biotechnology
Athersys Inc is a biotechnology company. It is focused on developing novel and proprietary therapies in the areas where there is an unmet medical need, particularly in the regenerative medicine area. The firm's main product is Multistem cell therapy. Its current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders and certain pulmonary conditions. Its revenue has been derived from corporate collaborations, license agreements, and government grants.
Read More

Earnings

see more
Q2 2022Est.ActualSurprise
EPS
(EXPECTED)2022-08-08
REV
Q1 2022Est.ActualSurprise
EPS-0.100-0.090 0.0100
REV690.000K2.912M2.222M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Athersys Questions & Answers

Q
How do I buy Athersys (ATHX) stock?
A

You can purchase shares of Athersys (NASDAQ: ATHX) through any online brokerage.

View our list of the best stock brokerages.

Q
Who are Athersys's (ATHX) competitors?
Q
What is the target price for Athersys (ATHX) stock?
A

The latest price target for Athersys (NASDAQ: ATHX) was reported by B of A Securities on Monday, May 23, 2022. The analyst firm set a price target for 0.25 expecting ATHX to rise to within 12 months (a possible 0.93% upside). 3 analyst firms have reported ratings in the last year.

Q
Current Stock Price for Athersys (ATHX)?
A

The stock price for Athersys (NASDAQ: ATHX) is $0.2477 last updated July 6, 2022, 8:00 PM UTC.

Q
Does Athersys (ATHX) pay a dividend?
A

There are no upcoming dividends for Athersys.

Q
When is Athersys (NASDAQ:ATHX) reporting earnings?
A

Athersys’s Q2 earnings are confirmed for Monday, August 8, 2022.

Q
Is Athersys (ATHX) going to split?
A

There is no upcoming split for Athersys.

Q
What sector and industry does Athersys (ATHX) operate in?
A

Athersys is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.